Description
A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
Locations:
Alta Bates Summit Medical Center: Please contact Trisha Smallwood SmallwTA@sutterhealth.org about Study D8110C00001 (Covid-19)
View study details on ClinicalTrials.govPrincipal Investigator
Recruitment Status
Active, Recruiting
Start Date
August 28, 2020
Related Studies
COVID-19 Universal Registry for Vital Evaluations (CURVE) Project
Investigators: Jiang Li, Ph.D., MPH, Robert Romanelli, Ph.D., MPH
Impact of COVID-19 on Cancer Care Management
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Maternal CARE Study
Investigators: Alice R. Pressman, Ph.D., M.S., Gregory J. Tranah, Ph.D.
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Investigator: Jiang Li, Ph.D., MPH